Inner page banner-company profile
CURRENT POSITION: HOME > ABOUT > COMPANY PROFILE

Construction land 

130 acres

Total surface area

150,000 square meters

Total planned investment

3 billion yuan

Main Products/ MAIN PRODUCTS

Drug Name

         Indications         

         preclinical

         IN        

         Stage I        

         II period        

         III period         

         NDA         

         listing         

Recombinant human serum albumin/granulocyte stimulating factor fusion protein for injection

Necrosis

✓✓✓✓


Recombinant human serum albumin/erythropoietin fusion protein for injection

anemia

✓✓✓



Recombinant monoclonal antibody series pharmaceutical injection products

Osteoporosis, etc.

✓





Tumor immunotherapy antibody fusion protein BY24.26

the tumor

✓





Tumor immunotherapy antibody fusion protein BY24.3

the tumor

✓





Anti-IL-17/TNFR fusion protein

autoimmune disease

✓